Advertisement

Related Videos

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Opening Session Panel Discussion

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Advertisement

Advertisement




Apr
22
Today In Oncology
Metastatic NSCLC Deep Learning Pathomics Platform May Help Predict Response to Immunotherapy
High-Risk Smoldering Multiple Myeloma: BCMA-Directed CAR T-Cell Therapy Shows Activity
Methylation-Based AI Model Classifies Tumors of Unknown Origin
Initial Data Shows Safety for WEE1 PKMYT1 Inhibitor Combination in Advanced Solid Tumors
‘Prostate Screening Saved My Life’—Is That Really True in Most Cases?
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo